Oncology Institute (TOIIW) Capital Expenditures (2021 - 2026)

Oncology Institute (TOIIW) has reported Capital Expenditures for 6 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $1.0 million, up 217.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 11.61% YoY), and the FY2025 annual result was $3.2 million, down 15.54% from the prior year.
• Capital Expenditures was $1.0 million for Q1 2026 at Oncology Institute, down from $1.1 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $1.8 million in Q1 2023 and troughed at -$3.5 million in Q4 2022.
• Average Capital Expenditures over 5 years is $741058.8, with a median of $1.0 million recorded in 2022.
• Year-over-year, Capital Expenditures plunged 505.74% in 2022 and soared 250.25% in 2025.
• Over 5 years, Capital Expenditures stood at -$3.5 million in 2022, then jumped by 124.36% to $861000.0 in 2023, then jumped by 103.83% to $1.8 million in 2024, then plunged by 39.6% to $1.1 million in 2025, then slipped by 1.7% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $604000.0 in Q3 2025.